BIOCRYST PHARMACEUTICALS, INC. Paid-in-Kind Interest
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Paid-in-Kind Interest of $7.14 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaidInKindInterest · last filed 2023-05-08
- BIOCRYST PHARMACEUTICALS, INC. paid-in-kind interest for the quarter ending 2023-03-31 was $7.14M, a 65.29% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. paid-in-kind interest for the quarter ending 2022-03-31 was $4.32M, a 21.75% increase year-over-year.
- BIOCRYST PHARMACEUTICALS, INC. paid-in-kind interest for the quarter ending 2021-09-30 was $4.36M.
- BIOCRYST PHARMACEUTICALS, INC. paid-in-kind interest for the quarter ending 2021-06-30 was $3.91M.
| Period end | Paid-in-Kind Interest 3 month | Paid-in-Kind Interest 6 month | Paid-in-Kind Interest 9 month | Paid-in-Kind Interest 9 month as first filed |
|---|---|---|---|---|
| 2023-03-31 | $7.14M 10-Q · filed 2023-05-08 | |||
| 2022-09-30 | $15.31M 10-Q · filed 2022-11-04 | |||
| 2022-03-31 | $4.32M 10-Q · filed 2023-05-08 | |||
| 2021-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $8.27M derived: sum of 2 quarters · filed 2022-11-04 | $11.81M 10-Q · filed 2022-11-04 | $12.87M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $7.46M 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | $3.55M 10-Q · filed 2021-05-07 | |||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |